CancerCare Manitoba
🇨🇦Canada
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- CancerCare Manitoba
- Target Recruit Count
- 6
- Registration Number
- NCT00524667
- Locations
- 🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada
© Copyright 2024. All Rights Reserved by MedPath